ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →
Wednesday, 18 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Investor Presentation

Star Imaging and Path Lab Investor Presentation: Key Takeaways

H1 FY27 revenue rose 8% YoY to ₹48.9 Cr, but EBITDA fell 18% to ₹14.1 Cr and PAT fell 22% to ₹7.8 Cr. B2C and B2B drove growth while margins compressed.

Highlights
Revenue growth8% YoY to ₹48.9 Cr
MarginsEBITDA margin 28.9% vs 38.2%; PAT margin 16.0% vs 22.2%
Demand visibility150+ B2B tie-ups; three PPP projects pending MOU signing

Growth

Revenue +8% YoY to ₹48.9 Cr; B2C +21%, B2B +20%, B2G -1%. Radiology +6%, pathology +17%.

Outlook

FY27 capex ₹20-25 Cr; Dwarka centre due end-November (PCPNDT approval pending, ₹5-6 Cr initial revenue); three PPP projects in pipeline.

Risks

EBITDA margin down 936 bps to 28.9%; operating cash flow negative at ₹(6.2) Cr; receivables up to ₹64.0 Cr; opex up 23%.

Source

Investor Presentation filed with BSE, BSE: 544482. Summary written with AI assistance from the document.

Read the document ↗

Star Imaging and Path Lab Ltd: key numbers

Share price
₹63.40
Market cap
₹110.4 Cr
Revenue (annual)
₹88.53 Cr
Net profit (annual)
₹19.28 Cr
P/E (TTM)
5.7×Sector 56.7×
Promoter holding
71.92%
FII holding
0.06%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Star Imaging and Path Lab Ltd

All →
16:11 IST BSE
Partnership

Star Imaging and Path Lab Partnership

Star Imaging and Path Lab entered an MoU with BSES Yamuna Power for empanelment as a designated diagnostic centre, valid to 31 December 2027. Services are provided at CGHS rates with no stated contract value.

Execution
Valid up to 31 December 2027